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Abstract Article Info 
Introduction: Nasopharyngeal cancer is the most common malignant tumour of the head and neck that caused 
high mortality. Most of patients came for treatment in late stage with enlargement of the neck lymphnode. 
Cancer stem cells are characteristic of stemness such as self-renewal and survival that caused tumour metastasis 
and recurrence. CD44, SOX2 and CCR7 are marker for NPC stem cells. 
Methods: Nine new patients NPC, WHO type III, positive LMP1 were examined for volume of the neck 
lymphnode, CD44, SOX2 and CCR7 expression before and after treatment chemotherapy cisplatin based. 
Staging determined by AJCC/UICC 2010.  
Results: The results of this study showed that all subjects have increased SOX2 and CCR7 expression after 
treatment with statistically negative correlation. CD44 did not altered before and after treatment and cannot be 
evaluate. Correlation between alteration of the increase SOX2 and CCR7 expression and reduction of the volume 
have shown statistically positive correlation. 
Conclusion: Neoadjuvant Chemotherapy Cisplatin based eliminated progenitor cells but did not for cancer stem 
cells in NPC. This result indicates that NPC with higher cancer stem cells must be more attention forward 
potential resistance and recurrence of the tumour, although the have received all standard neoadjuvant 
chemotherapy   
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Nasopharyngeal Cancer (NPC) is the most common malignant tumour of 
head and neck that caused high mortality. Most of patients came for treatment 
with late stage of cancer. Neck tumour is very often as a first symptom or sign 
that stimulate patients to looked for hospital medication [1].  
EBV-encoded latent membrane protein-1 (LMP-1) could induce 
development of CD44⁺ stem- like cell in NPC. The molecular modulation 
of CSC m NPC could shown that LMP-1 induced CSC through promotion 
of the expression of Epithelial-mesenchymal transition (EMT) [2-4]. 
LMP-1 provided and activated PI3-K/AKT pathway and subsequently 
important for induction and maintenance of LMP-1 induced CD44⁺ also 
activated PI3-K/AKT pathway. LMP-1 transformed cells led to 
phosphorylation to activated PI3-K/AKT pathway and induced CSC [5, 6]. 
  Cancer stem cells are small population with characteristic of stemness 
such as self-renewal and survival that caused tumour metastasis and 
recurrences [7, 8]. NPC cancer stem cells are characterized by CD44⁺, 
SOX2 and CCR7 [9-12]. 
CD44⁺ as a receptor for hyaluronic acid (HA) high expression in 
transmembrane cells. CD44⁺ also receptor for extracellular matrix (ECM) 
and co-receptor for growth factors and cytokine. CD44v isoform are CSC 
markers and critical regulators of cancer stemness including self-renewal, 
tumour initiation and metastasis (Sex determining region Y)-box2 (SOX2) 
is a transcription factor that is important and essential for maintaining self-
renewal, or pluripotency of embryonic stem cells. SOX2 also potential for 
somatic stem cells population maintenance, positive regulation of cell-cell 
adhesion, negative regulation of canonical Wnt signalling pathway and cell 
differentiation. SOX2 gene encodes transcription factor with function as an 
activator or suppressor of gene transcription. Recent finding SOX-2 also 
involved in cancer biology process especially in the fields of cellular 
signalling and cancer stem cells (5,6) In clinical settings, SOX-2 has shown 
a highly  influence on patient survival and prognosis, possible therapeutic 
intervention in the future [9, 10]. 
Chemokine (C-X-C motif) Receptor7 (CCR7) is a chemokine contain 
small peptide receptor binding which act as chemo-attractants for leucocyte 
lead to inflammation site. CCR7 involved in angiogenesis and malignant 
metastatic mechanism. Many researchers clarified that CCR7 functionally 
as a receptor for chemokine (C-X-C motif) ligand 19 and 21 in head and 
neck cancer patients. High expression of CXCR4 (SDF-1) and CCR7 have 
significantly correlated with regional and distant metastatic mechanism in 
head neck cancer [11, 12] 
2. MATERIAL AND METHODS 
Study design is observational cross sectional. We conducted to nine 
subjects who presented to ENT clinic at dr. Saiful Anwar Government 
Hospital, Malang by consecutive sampling. 
2.1 Inclusion criteria 
All subjects was diagnosed new NPC, WHO type III and positive LMP-
1 after they agreed informed consent for this study. Stage of NPC determine 
according to AJCC/UICC 2010. All of subjects have late stage with module 
in the neck, varies in size. They never received standard treatment for cancer 
before this study. Karnofsky score more than 80.  
 
2.2 Subject Measurement 
 
Nine subjects measured lymphnode volume before and after treatment. 
All of biopsy tissues before and after treatment have been examined for 
immunohistochemistry (IHC) CD44⁺, SOX2, CCR7. CD44⁺ were evaluated 
by software immune membrane and for SOX2 and CCR7 by software 
Immunoratio. 








CD44, SOX2, CCR7 Before and after Neoadjuvant Chemotherapy. 
Measurement of CD44⁺ expression by immunomembrane shown all subject 
have some result 3⁺ before and after treatment. Statistic analysis for all 
CD44⁺ expression can not be evaluated as planned before study. 
Table 1.  Descriptive analysis SOX2 Expression before and after treatment 
 SOX2 Expression 
Before After P 
Average 29.18 35.88  
Standard deviation  11.19 10.21 0.008 
Mean 26.70 31.20  
Wilcoxon test shown significant difference SOX-2 expression before 
and after treatment. 
Table 2.  Analysis Descriptive CCR7 Expression before and after treatment 
 CCR7 Expression 
Before After P 
Mean 30.21 34.34  
Standard deviation  10.57 10.20 0.008 
Median 26.70 30.50  
Wilcoxon test shown significant difference CCR-7 expression before 
and after treatment. 
Table 3.  Analysis Descriptive lymphnode volume before and after treatment 
 Lymphnode volume 
Before After P 
Mean 293.38 110.38  
Standard deviation  310.63 186.01 0.008 
Median 159.51 8.184  
Wilcoxon test shown significant difference lymphnode volume before 
and after treatment.Correlation between SOX2 expression and alteration of 
lymphnode volume shown by Spearman correlation test resulted negative 
correlation before and after treatment with coefficient of 0.379 (moderate 
correlation). The increased of SOX2 expression correlated with decreased 
of lymphnode volume, also meant that smaller treatment response. 
 
Picture 1. Corelation SOX2 expression before treatment with reduction of 
lymphnode volume 
 
Picture 2. Corelation CCR7 expression before treatment with reduction of 
lymphnode volume 
Correlation between CCR7 expression and alteration of lymphnode 
volume shown by Spearman correlation test resulted negative correlation 
before and after treatment with coefficient 0.134 (weak correlation). It is 
meant that increasing of CCR7 expression correlated with decreasing 
lymphnode volume, also shown smaller treatment response. 
3.1 Analysis between alteration of CD44⁺ , SOX2 and CCR7 
expression and lymphnode volume before and after treatment 
Analysis of CD44⁺ expression before and after treatment cannot 
evaluated because same result before and after treatment. Also for analysis 
between CD44 expression and lymphnode volume cannot evaluated because 
of same reason above. 
Table 4. Spearman Test Correlation Alteration of SOX2 expression and 
Lymphnode volume after treatment 
 Alteration Before and After Treatment 
SOX2 Lymphnode volume Coeff. correlation P 
Average 29.50 80.23   
Standard deviation  36.81 21.62 0.293 0.444 
Mean 10.86 91.80   
Table 5. Spearman Test Correlation Alteration of CCR7 expression and 
Lymphnode volume after treatment 
 Alteration Before and After Treatment 
CCR7 Lymphnode volume Coeff. correlation P 
Average 15.183 80.23   
Standard deviation  11.282 21.62 0.201 0.604 
Mean 10.462 91.60   
All subject shown increase SOX2 and CCR7 expression after treatment. 
Spearman test result positive correlation between percentage alteration of 
lymphnode volume (decreased) and percentage alternation of SOX2 and 
CCR7 expression (increased) with coefficient correlation 0.293 for SOX2 
and 0.201 for CCR7. This result meant higher increased SOX2 and CCR7 
expression would be more decreased lymphnode volume. The correlation 
above statistical not significant (P=0.444; P=0.604) 
4. DISCUSSION 
All subject of this study are NPC WHO type III with positive LMP-1 
and all in late stage according to American Joint Committee 
Cancer/International Union Against Cancer (AJCC/UICC) 2010. 9 subjects 
contain of six males and three females with age 40-56 years. All of patients 
have many size enlargement of neck lymphnode. 
Treatment in this study are neoadjuvant chemotherapy cisplatin-based 
give for three times with three weeks interval. Measurement of all variable 
have done before and after treatment. CD44⁺ which did not alter expression 
shown that LMP-1 modulated NPC stem cells through promotion of the 
EMT [2-4]. LMP-1 also provided and activated PI3-K/AKT pathway that 
very important for induction and maintain of CSC properties in NPC [5, 6]. 
CD44 is once of cell surface markers which expressed in the membrane 
cells. CD44 as a receptor for ECM, growth factors and cytokine, have 
critical role as regulators of cancer stemness including self-renewal, tumour 
initiation and metastasis [5, 6]. 
Expression SOX2 after treatment increased significantly. SOX2 
regulate EMT and involved at the metastasis, invasion and migration 
process. SOX2 also preserved CSC phenotype by modulation of histone 
acetyltransferase (HAT) [9, 10]. NPC stem cells contain of high level of 
SOX2, OCT4 and Nanog. High expression of SOX2 can be founded in 
cancerous tissue but only 5% expressed in normal tissue [9]. High 
expression of SOX2 are correlated with ability to pluripotency, 
progressivity, aggressiveness and invasion. Once study clarified that NPC 
stem cells which expression of SOX2 are correlated with metastatic ability 
to lymphnode and predicted poor prognosis [9, 10]. 
Expression of CCR7 increased after treatment. It is shown that CCR7 
has been high expressed in head and neck cancer. Secondary lymphnode as 
main sites for metastatic of many cancers. CCR7 mediated expansion of the 
cancer cells to lymphnode by PI3-K/AKT pathway [11, 12]. 
CCR7 and CXCR4 have correlated significantly to the patients with 
lymphnode metastasis compared to patient without lymphnode metastasis. 
CCR7 more linked with late stage cancer, but CXCR4 mostly founded 
significantly high in patient with distant metastasis [13-15]. CCR7  also 
upregulated MMP9 which subsequently lead the dendritic cell to move to 







the lymphnode and increased resistance to the treatment [16, 17]. NPC as 
an epithelial malignancy have close related to EBV and shown highly ability 
to invasion and metastasis, subsequently predicted to poor prognosis 
because of resistance to therapy [16-19]. 
CCR7 mostly expressed in cells highly built spheroid in NPC and 
correlated with metastatic to the lymphnode. CCR7 expression also 
contributed to recurrence and distant metastatic process. 
Nine subjects was given neoadjuvant chemotherapy according to the 
standard procedure, three times with three weeks time interval. We used 
chemotherapy cisplatin based for NPC patient was killed eliminated all 
cancer cells, altered cancer cells to be more sensitive to radiation and can be 
eliminate systemic micro metastatic molecules as early as possible. Also all 
patients must have been waited for radiation because of lack radiotherapy 
facilities for long time 6-12 months. 
All subjects shown decreases of the lymphnode volume significantly. It 
was compared to the result of increased SOX2 and CCR7 expression and 
level of CD44⁺ which did not altered after treatment. There was explained 
that NPC progenitor cells still sensitive to the chemotherapeutic agent. We 
founded negative correlation between CD44⁺, SOX2, CCR7 expression 
with reduction lymphnode volume before treatment and positive cumulation 
after treatment. 
5. CONCLUSION 
Neoadjuvant chemotherapy cisplatin based can be eliminated 
progenitor cells, but did not for cancer stem cells (CD44⁺) SOX2 and CCR7 
in NPC. Positive correlation between alteration of SOX2 and CCR7 
expression after treatment indicate that higher increase of cancer stem cells 
expression will following with high reduction lymphnode volume. We must 
pay more attention or more focus toward resistance of the cancer stem cells 
in NPC after treatment because of the potential tumour recurrence in the 
future although they have been received all standard therapy for NPC. 
REFERENCE 
[1] Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, 
Gondhowiardjo S, et al. Nasopharyngeal carcinoma in Indonesia: 
epidemiology, incidence, signs, and symptoms at presentation. 
2012;31(4):185. 
[2] Lai H-C, Hsiao J-R, Chen C-W, Wu S-Y, Lee C-H, Su I-J, et al. 
Endogenous latent membrane protein 1 in Epstein–Barr virus-infected 
nasopharyngeal carcinoma cells attracts T lymphocytes through 
upregulation of multiple chemokines. 2010;405(2):464-73. 
[3] Zheng H, Li L, Hu D, Deng X, Cao YJCMI. Role of Epstein-Barr virus 
encoded latent membrane protein 1 in the carcinogenesis of 
nasopharyngeal carcinoma. 2007;4(3):185-96. 
[4] Tabyaoui I, Serhier Z, Sahraoui S, Sayd S, Cadi R, Bennani O, et al. 
Immunohistochemical expression of latent membrane protein 1 
(LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience. 
2013;13(3):710-7. 
[5] Lun SW-M, Cheung ST, Cheung PFY, To K-F, Woo JK-S, Choy K-W, 
et al. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal 
carcinoma. 2012;7(12):e52426. 
[6] Trapasso S, Allegra EJBt, therapy. Role of CD44 as a marker of cancer 
stem cells in head and neck cancer. 2012;6:379. 
[7] Zhang Z, Sant’Ana Filho M, Nör JEJOo. The biology of head and neck 
cancer stem cells. 2012;48(1):1-9. 
[8] Visvader JE, Lindeman GJJCsc. Cancer stem cells: current status and 
evolving complexities. 2012;10(6):717-28. 
[9] Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T, et al. SOX2 promotes tumor 
metastasis by stimulating epithelial-to-mesenchymal transition via 
regulation of WNT/β-catenin signal network. 2013;336(2):379-89. 
[10] Dong Z, Liu G, Huang B, Sun J, Wu DJIjoc, medicine e. Prognostic 
significance of SOX2 in head and neck cancer: a meta-analysis. 
2014;7(12):5010. 
[11] Zhang W, Tu G, Lv C, Long J, Cong L, Han YJB, et al. Matrix 
metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via 
PI3K/Akt pathway and is involved in CCL19-driven BMSCs 
migration. 2014;451(2):222-8. 
[12] Allavena P, Germano G, Marchesi F, Mantovani AJEcr. Chemokines 
in cancer related inflammation. 2011;317(5):664-73. 
[13] Dean M, Fojo T, Bates SJNRC. Tumour stem cells and drug resistance. 
2005;5(4):275. 
[14] Lun SW-M, Cheung ST, Cheung PFY, To K-F, Woo JK-S, Choy K-W, 
et al. Cancer Stem-like Cells in Epstein-Barr Virus-Associated 
Nasopharyngeal Carcinoma. Chinese Journal of Cancer. 
2014;33(11):529-38. 
[15] Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MFJCoig, 
development. Therapeutic implications of cancer stem cells. 
2004;14(1):43-7. 
[16] Thomas M, Coyle K, Sultan M, Vaghar-Kashani A, Marcato PJC. 
Chemoresistance in cancer stem cells and strategies to overcome 
resistance. 2014;3(125):2. 
[17] Yu H, Zhang C, Wu YJCJC. Research progress in cancer stem cells 
and their drug resistance. 2010;29(3):261-4. 
[18] Abdullah LN, Chow EK-HJC, medicine t. Mechanisms of 
chemoresistance in cancer stem cells. 2013;2(1):3. 
[19] Liu F-Y, Safdar J, Li Z-N, Fang Q-G, Zhang X, Xu Z-F, et al. CCR7 
regulates cell migration and invasion through JAK2/STAT3 in 
metastatic squamous cell carcinoma of the head and neck. 2014;2014. 
 
